Enlighten me, please, Craig. What do you consider an appropriate package. I’d also love to hear OHM’s opinion on this. With 700 million shares, what would be a “fair” price/deal? Also, we have the Vyera deal plus the royalties we will owe. Nader seems to be very keen on the idea of taking this as far as it can go, per CC. Remember this is a man who has taken a shelved drug to where we are today. However, as the decision depends ultimately on shareholders, I’m interested in knowing what could be a “good deal” for us.